Monovalent Rotavirus Vaccine Efficacy Against Different Rotavirus Genotypes: A Pooled Analysis of Phase II and III Trial Data is a research paper published in Clinical Infectious Diseases (2022). On theSindex it has a DataRank of 0.425. It has been cited 16 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.425
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Allergy and Infectious Diseases
Grant: R01 GR111026
National Institute of Allergy and Infectious Diseases
Grant: R01 AI148127
NIH
Grant: R01 GM124280
NIAID NIH HHS
Grant: R01 AI112970
National Institutes of Health
Grant: 5R01AI148127-03
Emerging methods and applications for test-negative studies of of infectious disease interventions
National Institutes of Health
Grant: 3R01GM124280-04S1
Modeling ongoing SARS-CoV2 vaccination strategies in light of emerging data on immunity and viral evolution
NIGMS
GlaxoSmithKline
FWCI
1.55
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals